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Abstract 
Pin1 is a phosphorylation-dependent peptidyl-prolyl isomerase that has 
been shown to be neuroprotective in aging-related neurodegenerative diseases 
such as Alzheimer's disease (AD).  However, it is not active in AD brain, and a 
recent proteomic screen of Mild Cognitive Impairment (MCI) brain samples 
revealed that Pin1 is oxidized in the brains of these pre-AD patients.  This 
suggests that this oxidation may be the cause of the loss of the neuroprotective 
Pin1 function in AD.  The Pin1 active site contains a functionally critical cysteine 
residue (Cys113) with a low predicted pKa, making it highly susceptible to 
oxidation.  We hypothesize that Pin1 is inhibited by oxidation of this cysteine.  
This hypothesis was tested using enzyme activity assays, mutational analysis, and 
structural studies.  We conclude that the loss of Pin1 activity due to oxidation can 
be isolated to the oxidative modification of Cys113, and reveals a potential 
mechanism for countering this loss of function. 
Keywords 
Neurodegeneration, Alzheimer’s disease, Peptidyl-prolyl cis-trans 
isomerase Pin1, Oxidation, Redox signaling, Peptidyl-prolyl isomerase assay, X-
ray crystallography. 
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Introduction 
The peptidyl-prolyl cis/trans isomerases (PPIases) are a class of enzymes 
that catalyze the cis/trans isomerization of the peptide bond preceding a proline 
residue.  Until the early 1990s, the two families of PPIases, the cyclophilins and 
FKBPs, were known for their role in protein folding and chaperone functions, and 
the immune responses associated with their respective inhibitors.1,2  The existence 
of a third, cyclophilin A- and FK506-insensitive PPIase family, the parvulins, was 
confirmed in 1994 by Gunter Fischer's group.  In 1996 Tony Hunter's lab 
identified a phosphate-directed parvulin interacting with NIMA that was critical 
for mitotic regulation and homologous to the essential yeast parvulin Ess1.3-6  
This protein, Pin1, became a subject of interest in terms of a number of different 
diseases due to the unique nature of its phosphate-directed substrate specificity. 
 
1.1 The biochemistry of the phosphate-directed binding and 
isomerase activity of Pin1 
Pin1 is an 18 kDa parvulin made up of a 39-residue class IV WW domain 
and the catalytic PPIase domain, connected by a short, flexible linker, as shown in 
Figure 1-1.  Both the WW and PPIase domains exhibit similar specificity for the 
phosphorylated target sequence of pSer/Thr-Pro. However, the WW domain, a 
small protein-interaction domain named for its two conserved Trp residues, binds 
with approximately 10-fold higher affinity to the canonical target peptide Pintide, 
while the PPIase domain in isolation was shown to be unable to bind to Pin1 
substrates.7  Nevertheless, the PPIase domain does exhibit phosphate-directed 
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binding and has structural elements critical for this function.8  Clearly identified 
in the original structure and confirmed by mutagenesis studies performed 
previously by the Litchfield lab, the residues Lys63, Arg68 and Arg69 form a 
positively charged pocket to coordinate the phosphorylated Ser/Thr, and are 
required for binding to most Pin1 substrates.3,9,10  It has been assumed that the 
WW domain of Pin1 was responsible for protein targeting and substrate 
recognition, with the PPIase domain simply catalysing the isomerization of the 
peptide bond.  However, it was recently proposed that the two domains may act in 
a concerted manner on some substrates by way of binding to multiple sites 
simultaneously.9  While the majority of Pin1 substrates have only one known 
binding site, a large minority possess multiple sites, and in most cases these sites 
are spaced approximately 20 residues apart, potentially allowing the WW domain 
to interact with one site, targeting the PPIase domain to isomerize the other.  This 
has been exemplified by NMR studies of Tau, which has been shown to have two 
Pin1 binding sites of similar affinity 19 residues apart, only one of which is 
isomerized by Pin1.11,12  In this study, the binding and catalytic activity of full-
length Pin1 was compared to that of the PPIase domain alone on peptides 
containing one or both Pin1 binding sites.  It was shown that while the WW 
domain enhances Pin1 activity when a single pTP site is present on the peptide, 
phosphorylation of the second site increased Pin1 binding affinity but decreased 
catalytic activity in a WW-domain-dependent manner.11  It is apparent that the 
two domains of Pin1 interact in a more complex manner than is suggested by the 
classical interpretation of their roles.  A better understanding of the regulatory 
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capacity of the WW domain when interacting with Pin1 may help explain some of 
the contradictions in its interactions when mediating tumourigenesis. 
The Pin1 active site has been known since its crystal structure (1PIN) was 
resolved in 1997 by Ranganathan et al.3  Cys113, His59, His157, and Ser154 
form a pocket around the peptide bond, lending evidence to the theory that unlike 
other PPIases, Pin1 catalyses the isomerization of its substrate through the 
formation of a covalently-bound tetrahedral intermediate species, as shown in 
Figure 1-2.  First, the phosphate group is localized to its binding pocket (as 
described above) bringing the peptide bond from 0° to 90°, thereby shifting the 
carbonyl oxygen of the substrate such that it no longer prevents the side-chain of 
Cys113 from entering the active site.  Cys113 is deprotonated by the nearby 
His59, allowing nucleophilic attack by the thiolate upon the carbonyl carbon of 
the substrate.  The resulting negative charge on the carbonyl oxygen is stabilized 
by proximity to His157.  This high-energy tetrahedral intermediate relaxes back 
into cis or trans conformation, and the substrate is released.  However, questions 
began to be raised regarding this model in 2002 with the publication of a solution 
structure of the Arabidopsis thaliana homologue of Pin1 (Pin1At) by Landrieu et 
al.13  The NMR data revealed that the C113 analog of Pin1At undergoes little 
change upon binding to an active-site ligand, suggesting that a covalent bond is 
not formed.  Following this, a series of reports from the Litchfield lab tested this 
model through mutagenesis and catalytic activity studies, and found it to be 
inaccurate.  In 2007, Behrsin and colleagues performed a unigenic evolution study 
that revealed, among other things, that Cys113 does not act as a nucleophile.10  
 4 
 
While this residue was conserved in the initial unigenic evolution experiment, 
targeted mutation to a serine, which would have maintained its role as a 
nucleophile, abolished Pin1 activity, whereas mutation to an aspartic acid 
maintained approximately 30% activity.  This suggests that a negatively-charged 
environment at position 113, rather than a nucleophile, is critical for the Pin1 
catalytic mechanism.  Further evidence against the classical view was provided by 
Bailey et al. the following year, by showing that His59 and His157 were not 
required to maintain the hydrogen-bonding network necessary to create the 
thiolate nucleophile at Cys113 or stabilize the tetrahedral intermediate, but instead 
were critical for maintaining protein stability.14  The critical experiment in this 
work was the rescue of the catalytically-inactive H59L mutation by mutating 
H157L, the effect of which was to increase protein stability and consequently 
enzyme activity.  Given the evidence for a negatively-charged environment 
around Cys113, Behrsin and colleagues proposed an alternative catalytic 
mechanism in 2007 similar to the bond-distortion mechanisms favoured by other 
PPIases.10  The chemical environment around Cys113 created by Ser111, Ser115, 
and a coordinated water molecule results in a very low predicted pKa for the 
residue.  This partial negative charge on the Cys113 allows it to stabilize the 
double-bond character of the carbonyl group of the substrate, rather than allowing 
a resonance structure to form, which would impart double-bond characteristics to 
the peptide bond to be isomerized.  Further studies regarding active-site chemistry 
will improve the understanding of the Pin1 catalytic mechanism, potentially 
facilitating development of methods of therapeutic regulation of the enzyme. 
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Figure 0-1.  The peptidyl-prolyl isomerase Pin1 with a substrate dipeptide. 
The crystal structure of R14A Pin1 solved as a part of this thesis, with a 
phosphoserine-proline substrate dipeptide (backbone carbons in bright yellow) 
modelled into the active site based on the location of analogous chemical groups 
in the active site inhibitor bound to Pin1 in the crystal structure 2ITK.63  The 
backbone trace of Pin1 is coloured to reflect different groups, while the elements 
of rendered amino acids are coloured in this and subsequent figures using the 
standard colour scheme of oxygen in red, nitrogen in blue, sulphur in yellow, and 
phosphorus in orange.  The WW domain is shown in purple, with the pink ends of 
the backbone trace indicating the start and end of the 12 residue long unresolved 
linker region.  The isomerase domain is in dark grey, with the catalytic face 
highlighted.  In green is the hydrophobic pocket, which interacts with the 
substrate proline, and in pink is the phosphate binding loop.  The blue region is 
the catalytic pocket, containing a conserved hydrogen bonding network (shown 
with yellow dashed lines).78  Important residues contributing to the functions of 
each area are shown. 
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Figure 0-2.  The various models of the Pin1 catalytic mechanism. 
Top left shows the resonance double-bond nature of the peptide bond.  The 
covalent mechanism is as follows: First, the phosphate group is localized to its 
binding pocket, described above, bringing the peptide bond from 0° to 90°, 
thereby shifting the carbonyl oxygen of the substrate such that it no longer 
prevents the side-chain of Cys113 from entering the active site.  Cys113 is 
deprotonated by the nearby His59, allowing nucleophilic attack by the thiolate 
upon the carbonyl carbon of the substrate.  The resulting negative charge on the 
carbonyl oxygen is stabilized by proximity to His157.  This high-energy 
tetrahedral intermediate relaxes back into cis or trans conformation, and the 
substrate is released.  The non-covalent mechanism is as follows: The chemical 
environment around Cys113, created by Ser111, Ser115, and a coordinated water 
molecule, results in a very low predicted pKa for the residue.  This partial 
negative charge on the Cys113 allows it to stabilize the double-bond character of 
the carbonyl group of the substrate, rather than allowing a resonance structure to 
form, which would impart double-bond characteristics to the peptide bond to be 
isomerized.  Adapted from Behrsin, et al., 2007.10 
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1.2 Pin1 as a target against proliferative signaling in cancer. 
Proline-directed phosphorylation is a subset of cell signalling involved in a 
variety of cell processes including cell-cycle regulation.  As the only known 
phospho-directed peptidyl-prolyl isomerase, Pin1 plays a critical role in mediating 
conformational changes involved in these signalling processes and is thus 
implicated in pathologies caused by failures in this machinery, such as cancer and 
neurodegeneration.  Pin1 has been shown to be overexpressed in a wide variety of 
cancers, including prostate, lung, ovarian, cervical, brain tumours, and melanoma, 
and that heightened protein levels correlate with poorer clinical outcomes in 
prostate cancer.15-17  While Pin1 positively regulates a number of oncogenes and 
inhibits some tumor suppressors, its most apparent oncogenic role is in Her2/Neu- 
or Ras-mediated tumours.18  Mouse models have demonstrated that 
overexpression of Pin1 enhances Neu and Ras oncogenicity, while Pin1-null mice 
are Neu and Ras resistant.19,20  Both these proteins upregulate the transcription 
factor E2F, which in turn upregulates both Pin1 and cyclin D1.  Pin1 interacts 
with cyclin D1, preventing its export from the nucleus and subsequent targeting to 
the proteasome.20  Furthermore, Pin1 enhances cyclin D1 transcription by 
facilitating upstream signalling factors.  Pin1 interacts with phosphorylated Jun 
N-terminal kinases, allowing them to phsophorylate c-Jun and subsequently 
trigger transcription of cyclin D1.17  Pin1 interaction with β-catenin prevents its 
turnover and targets it to the nucleus, thereby activating transcription of cyclin 
D1.21  Finally, Pin1 isomerizes the p65/RelA binding site of NfκB, thereby 
freeing it from its inhibitor and allowing it to accumulate in the nucleus, 
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enhancing transcription of cyclin D1.22  Cyclin D1 drives cell cycle progression 
and enhances E2F transcription, creating a positive feedback loop mediated by 
Pin1 that is used by the oncogenes Her2/Neu and Ras to promote proliferation in a 
variety of cancers.  Thus, it is clear that Pin1 could serve as a novel therapeutic 
target for the treatment of these cancers. 
 
1.3 The loss of Pin1 activity is implicated in the development of 
neurodegenerative disease. 
The loss of Pin1 activity is has been suggested as a causative factor in a 
variety of age-related neurodegenerative pathologies.  While Pin1-null mice 
display no apparent developmental phenotype and show lower onset and 
increased resistance to some types of tumour formation, they do show signs of 
aging much earlier than their wild-type counterparts, including neuronal 
degeneration.23,24  In fact, the loss of Pin1 function has been proposed as a 
causative factor in Alzheimer's disease (AD), a neurodegenerative disease that 
results in large-scale loss of neurons in the hippocampus, the brain region 
responsible for memory.  Post-mortem diagnosis of AD is based on the presence 
of two molecular pathologies, intracellular neurofibrillary tangles (NFT) and 
extracellular β-amyloid (Aβ) plaques, both of which can be mitigated by Pin1 
activity.25,26  Hyperphosphorylation of the microtubule-binding protein Tau has 
been implicated in the formation of NFT.  Pin1 binds to at least one 
phosphorylation site on Tau, and can reverse this loss of microtubule binding, 
thereby preventing aggregation of the protein.27,28  Conversely, if Pin1 is not 
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available to mediate isomerization at this site, phosphorylation triggers misfolding 
of Tau, allowing the pathological aggregates to form.29  β-Amyloid (Aβ) plaques 
are amyloids formed by the deposition of the insoluble Aβ42 peptide 
extracellularly.  Aβ42 is produced by the sequential processing of the trans-
membrane amyloid precursor protein (APP) by β- and γ-secretases.  This 
processing is mediated by phosphorylation of APP at Thr668, but as with Tau, 
Pin1-mediated isomerization at this site prevents pathogenic cleavage.23   
The concentration of Pin1 in neuronal cells is reduced and its normal 
subcellular localization to the nucleus is aberrant in Alzheimer’s disease.30,31  
These early studies suggested that Pin1 expression is reduced in AD and this 
reduction fuels the progression of AD pathologies, such as AB plaques and NFT, 
that would have otherwise been prevented by Pin1.  However, these studies never 
directly measured Pin1 expression levels (ie. by qPCR of Pin1 mRNA), instead 
drawing this conclusion based on the reduced concentration of soluble Pin1 in AD 
neurons.  Spurred on by the spread of this conclusion to a number of reviews,32-37 
a number population studies of the effect of Pin1 promoter polymorphisms on AD 
onset and progression were undertaken.  These studies were not able to draw a 
genetic link between Pin1 and Alzheimer’s disease progression, nor show that 
Pin1 expression is decreased in AD.38-42  A more likely explanation for the loss of 
soluble Pin1 in AD stems from its interaction with the insoluble cellular infarcts 
characteristic of AD, Aβ plaques and NFT.  Studies have shown that Pin1 
associates with both neurofibrillary tangles and amyloid plaques; this causes a 
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reduction in the soluble fraction of Pin1 and a change in the localization from the 
nucleus to the cytoplasm.43,44 
Since Pin1 isomerase activity has been shown to mitigate the development 
of both Aβ plaques and NFT, there must be a different mechanism causing the 
loss of Pin1 function prior to the development of AD.  Mild Cognitive Impairment 
(MCI) is considered a precursor to Alzheimer’s disease 45.  Recent redox 
proteomic analysis of hippocampal samples from both MCI and AD patients has 
shown increased levels of oxidative stress in these patients and identified Pin1 as 
oxidized in both diseases.46,47  Pin1 is shown to have less isomerase activity in 
hippocampal samples of MCI and AD patients than age-matched controls, thus it 
was hypothesized that oxidation of Pin1 resulted in loss of function and 
subsequent development of neurodegenerative infarcts.  The hypothesized model 
for the role of Pin1 in AD progression is as follows: neuroprotective functions of 
Pin1 are lost as age-related oxidative stress inhibits Pin1, allowing the formation 
of neurofibrillary tangles and B-amyloid deposits, which then accelerate the loss 
of Pin1 function by sequestering it to the insoluble fraction.  In order to prevent or 
reverse this pathological loss of Pin1 activity, it is necessary to determine the 
biochemical mechanism of Pin1 inhibition by oxidation. 
 
1.4 Oxidative stress and protein modification 
The role of oxidative stress in the development of many aging-related 
pathologies, including Alzheimer’s disease, is well established.48  One of the main 
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sources of oxidative stress in neurodegeneration in general, and AD in particular, 
is the mitochondria. 49  Studies have correlated the increased oxidative damage in 
AD neurons with mitochondrial lysis.50  One of the major redox products 
generated by cellular respiration in the mitochondria is hydrogen peroxide (H2O2), 
a redox molecule capable of a variety of protein modifications, and implicated in 
many redox signaling pathways.51  One of the major peptide targets of H2O2 is the 
thiol group (-SH) on the side chain of cysteine.  H2O2 undergoes an SN2 reaction 
with cysteine-SH to produce cysteine sulfenic acid (Cys-SOH), which generally 
serves as a transition state in the development of other oxidative modifications of 
cysteine.52,53  As outlined in Figure 1-3, these include the formation of disulfide 
bonds, and further SN2 reactions with either backbone amines, or H2O2, to form 
sulfenylamides, or sulfinic (-SO2H) and sulfonic (-SO3H) acid.  
As outlined above, the catalytic pocket of Pin1 contains a cysteine residue 
with a low pKa, which increases its nucleophilicity, making it likely to partake in 
an SN2 reaction with H2O2.54-57  Given that this cysteine is implicated in the 
catalytic mechanism of Pin1 isomerization, this would suggest that Pin1 enzyme 
activity could be sensitive to oxidative stress. 
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Figure 0-3.  Hydrogen peroxide-mediated oxidation of cysteine. 
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1.5 Objective 
The loss of Pin1 activity is implicated in the development of Alzheimer’s 
disease, and evidence suggests that Pin1 is oxidized in the hippocampus of 
patients developing AD.  The biochemistry of Pin1 isomerase activity suggests 
that Pin1 may be sensitive to oxidative stress at the catalytically critical Cys113 
residue.  It was therefore hypothesized that Pin1 is inhibited by oxidative 
modification of Cys113.  This was tested first by establishing that Pin1 is 
inhibited by H2O2 using an assay of peptidyl-prolyl isomerase activity.  It was 
then determined that Cys113 was modified by oxidation, using a chemical tag 
specific to unmodified thiol groups.  The oxidation-mediated inhibition of Pin1 
was then shown to be dependent on the presence of Cys113, using a catalytically 
active Pin1 mutant lacking that residue.  X-ray crystallography was then 
performed to determine the structure of oxidized Pin1, and the presence of the 
oxidative modification found in the crystal structure was confirmed in vitro by 
mass spectrometry and further isomerase assays.  The validation of this 
hypothesis reinforces the theory that the loss of Pin1 function due to oxidation 
plays a role in the development of Alzheimer’s disease. 
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2 Materials and Methods 
2.1 Protein expression and purification. 
Recombinant R14A Pin1 and R14A C113D Pin1 were expressed in BL21 
E. coli carrying pProEX-HTA plasmids generously provided by Dr. Brian Shilton.  
Individual colonies were grown to an OD of 0.6 in L Broth with 100 µg/mL 
ampicillin (Roche) at 37 ºC, then expression was induced overnight at 18 ºC with 
0.6 mM isopropylthio-α-ᴅ-β-galactoside.  Bacteria were pelleted and resuspended 
in HEPES buffer (10 mM HEPES, 100 mM NaCl, 5 mM NaN3, pH 7.4) with 
protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 µg/mL pepstatin A, 
and 10 µg/mL leupeptin), then lysed by sonication.  The soluble fraction of 
bacterial lysate was separated by centrifugation.  The soluble lysate was loaded 
onto a 5 mL HisTrap HP nickel sepharose affinity column (GE Healthcare Life 
Sciences).  The column was washed with 20 column volumes of HEPES buffer 
containing 10 mM imidazole, followed by 10 column volumes of 50 mM 
imidazole, both of which were collected for quality assessment of the expression 
and purification.  His-tagged Pin1 was eluted in 500 mM imidazole – generally 
over the course of 2 column volumes, though protein content of the eluent was 
monitored by A280 using the ÄKTA FPLC system (GE Healthcare Life Sciences).  
The protein concentration of the eluted solution was determined by A280, TEV 
protease was added in a stoichiometric ration of 1:25, along 5 mM DTT.  This 
solution was rotated at room temperature for 2 hours, followed by the addition of 
a second aliquot of TEV and DTT.  The resulting solution was then dialyzed three 
times against at least 1 L of HEPES buffer for at least 4 hours at 4 ºC to remove 
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DTT.  The solution was then loaded onto a 5 mL HisTrap column where the 
flowthrough and 1 column volume of wash using HEPES buffer containing 10 
mM imidazole was collected.  This solution was dialyzed twice against 1 L of 
HEPES buffer containing 1 mM EDTA and 5 mM DTT for at least 4 hours at 4 ºC 
to remove imidazole, followed by once against HEPES buffer with no additives.  
Purified R14A Pin1 in HEPES buffer was concentrated to 15 mg/mL using an 
Amicon Ultra centrifugal filter tube and flash frozen for storage at -80 ºC. 
 
2.2 Oxidation of Pin1. 
Oxidation of Pin1 was done by adding H2O2 to a final concentration of 
either 500 µM or 1 mM when preparing the 20 µM stock solution of Pin1.  This 
was incubated for the reported duration (between 30 minutes and 4 hours) at 4 ºC 
before beginning the assay in question.  For subsequent treatment with DTT, 
H2O2 was decomposed by adding 400 units of catalase at room temperature for 15 
minutes, followed by 10 mM DTT for 30 minutes. 
 
2.3 Peptidyl-prolyl isomerase assays. 
Peptidyl prolyl isomerase assays were performed using recombinant Pin1 
and a previously published protocol.10,58  A stock solution of R14A Pin1 at 20 µM 
was prepared in the HEPES buffer defined above.  The substrate, succinyl-AEPF-
p-nitroanaline, was dissolved in LiCl/TFE (0.3 M LiCl dissolved in 
trifluoroethanol) to a stock concentration of 10 mM.  Chymotrypsin (Type II, 
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Sigma-Aldrich) was dissolved in 1 mM HCl to a concentration of 50 mg/mL.  
Assays were carried out at 0 ºC using a Cary-100 spectrophotometer, measuring 
absorbance at 405 nm.  Prior to beginning a run, 1.9 mL of HEPES buffer, minus 
the volume of substrate stock to be added, was mixed with the appropriate volume 
of substrate stock in a cuvette with a stirrer.  Multiple runs were collected with 
varying concentrations of substrate, to a maximum of 250 µM.  Data collection 
was started prior to the addition of chymotrypsin.  50 µL of chymotrypsin stock 
solution was added, and the burst phase and subsequent chemical isomerization 
rate were observed as changes in absorbance over time.  Once the rate was linear, 
50 µL of Pin1 stock solution was added, and the run was allowed to continue until 
all substrate had been consumed, as indicated by the absorbance progress curve 
reaching a slope of zero.  From the absorbance progress curve of each run, the 
initial rate of Pin1-mediated absorbance change was calculated by subtracting the 
slope of the linear region of the curve immediately prior to the addition of Pin1 
(the chemical isomerization rate) from the slope of the linear region of the curve 
immediately following Pin1 addition, and converted to measure of concentration 
per time using using Beer’s law, with an ε for pNA at 405 nm of 6026 cm-1 M-1.  
The absorbance just prior to Pin1 addition was subtracted from the final 
absorbance to give an absorbance due to the cis isomer of the substrate peptide, 
which was used to determine the concentration of the cis isomer (the substrate 
isomerized by Pin1).  The initial rate of Pin1-mediated change in substrate 
concentration, as calculated above, directly corresponds to isomerization by way 
of the subsequent isomer-specific proteolysis by chymotrypsin.  The plot of this 
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value ( 0v ) against substrate concentration, calculated above, can be fit to the 
linear reduction of the Michaelis-Menten equation, ][][ 00 SEK
k
v
M
cat
= , which is 
applicable when [substrate] ᴅ KM.  Thus kcat/KM was determined by dividing the 
slope of this line, which corresponds to ][ 0EK
k
M
cat
, by the final concentration of 
Pin1 in the assay. 
 
2.4 Protein thiol counting assay. 
Thiol counting by reaction with dithiodipyrimidine (DTDP) was done 
using recombinant Pin1 and an established protocol.59  Absorbance readings were 
taken at 324 nm.  For each experiment, the spectrophotometer was zeroed with 
120 µL of 20 µM Pin1 in HEPES buffer at pH 7.0.  After zeroing, 5 µL of 4 mM 
DTDP in 12 mM HCl was added, and the cuvette was then immediately vortexed.  
A324 readings were taken after incubating for 5 minutes at room temperature.  The 
absorbance of a reagent control (A324r), consisting of 120 µL of HEPES buffer 
with 5 µL of 4 mM DTDP, was also collected.  The concentration of thiol groups 
in the solution was determined by the following equation, where ε324 = 21400 cm-
1
 M-1 and   = 1 cm:  
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2.5 Crystallization of R14A Pin1. 
R14A Pin1 was crystallized by hanging drop vapour diffusion over 3 days 
in 2.0 to 2.4 M ammonium sulfate, 1% (v/v) poly(ethylene glycol) 400 (PEG400) 
and 100 mM HEPES at pH 7.8 and 4 °C.  Oxidized crystals were grown as above, 
with mother liquor containing 10 mM H2O2. 
 
2.6 X-ray data collection and refinement. 
Data was collected using a laboratory source and processed using 
MOSFLM and Scala.60,61  Structure solution and refinement was done by 
molecular replacement in PHENIX using 2ITK as the starting model for the 
untreated R14A Pin1 structure. 62,63  The oxidized Pin1 structure was solved by 
molecular replacement using the untreated structure as the starting model, and 
topology file CSW.cif from REFMAC5.64 
 
2.7 ESI mass spectrometry. 
Pin1 samples were analyzed using Q-TOF Ultima API (Waters, Milford, 
MA), with MassLynx V4.1 for analysis and data processing (The capillary 
voltage, 3 kV; cone voltage, 60 V; RF lens 1 voltage, 40 V; source temperature, 
80 °C; desolvation temperature, 250 °C. The cone and desolvation gas flow rates 
were 50 and 500 L/h, respectively) coupled to a Waters UPLC pump at a flow rate 
of 200 µL min-1, using a water/acetonitrile gradient in the presence of 0.1 % 
formic acid. 
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2.8 K-means clustering analysis. 
Clustering analysis of the isomerase rescue data was done using SciKit 
Learn, a python-based machine learning library.65  The sklearn.cluster.KMeans 
class was initialized with n_clusters = 3, and the fit(X) method was run on a 3-
dimensional array of isomerase activity vs. H2O2 concentration vs. duration of 
treatment.  The K-means clustering algorithm is formally described as follows: 
 
 
2.9 Statistics. 
All statistics were computed in Prism6 (Graphpad Software), using the 
analyses and n-values indicated in the respective figures. 
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3 Results 
3.1 Pin1 is inhibited by oxidation. 
The objective of this study is to investigate the mechanism in which Pin1 
is inhibited by oxidation.  First, the inhibitory effect of oxidation on Pin1, as first 
reported by Sultana et al., will be examined.47  Modification of the thiol of the 
active-site cysteine 113 is hypothesized to be the cause of oxidation-mediated 
inhibition of Pin1.  This hypothesis will be tested by comparing the effects of 
oxidation between wild-type Pin1 and a Pin1 mutant lacking a thiol in the active 
site.  The structure of oxidized Pin1 will be solved to determine whether the 
active site cysteine is modified by oxidation.  Finally, the potential functional 
implications of this redox modification of cysteine 113 will be explored. 
In order to examine the effect of oxidation on Pin1 structure and function, 
it was first necessary to assess the conditions under which Pin1 is inhibited by 
oxidation, as first demonstrated by Sultana et al.47  To do this, an in vitro 
spectrophotometric assay of isomerase activity was used to compare the activity 
of reduced versus oxidized Pin1.10,58,66  In brief, Pin1 isomerase activity is tracked 
by an increase in the concentration of the chromophore p-nitroanaline in solution 
by measuring absorbance at 410 nm.  The p-nitroanaline is present in the assay 
solution as part of a peptide substrate that undergoes a cis-trans isomerization 
catalyzed by Pin1, followed by cleavage by the trans-specific protease 
chymotrypsin.  The slope of the resulting absorption progress curve gives both the 
chemical and total isomerization rates of the peptide, thereby allowing for the 
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determination of the Pin1-catalyzed rate of isomerization of the substrate at a 
certain concentration of substrate.  By repeating this assay with low 
concentrations of the peptide relative to its Km, the linear initial slope of a 
Michaelis-Menten plot can be determined, thereby allowing Kcat/Km values to be 
determined for Pin1. 
Purified human Pin1 contain a substitution of Arg14 to alanine (R14A 
Pin1) was used for this and all subsequent experiments to represent wild-type 
Pin1, as the R14A mutation has no discernible effect on substrate binding or 
enzyme activity, while allowing for the growth of more stable crystals for x-ray 
crystallography.63,67  As seen in Figure 3-1, the Kcat/Km of reduced R14A Pin1 
with the substrate peptide succinyl-AEPF-pNA is approximately 336 +/- 57 mM-
1s-1, which is consistent with recombinant Pin1 activity values in the literature.10,58  
Oxidation of Pin1 was performed in vitro by pre-incubating 20 µM Pin1 with 500 
µM or 1 mM H2O2 (corresponding to molar ratios of 25:1 or 50:1 of H2O2 to 
Pin1) for 4 hours at 4 °C.  Activity of oxidized Pin1 was significantly inhibited by 
both treatments (P = 0.0019 by one-way ANOVA and Tukey’s multiple 
comparison post-test), with isomerase activity almost 100-fold lower than that of 
untreated Pin1.  This result confirmed that Pin1 is strongly inhibited by oxidation. 
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Figure 3-1.  Pin1 is inhibited by oxidation. 
Isomerase activity of R14A Pin1 was determined by a spectrophotometric assay 
using the peptide substrate succinyl-AEPF-p-nitroanaline.10  20 µM Pin1 was pre-
incubated with 500 µM or 1 mM H2O2 for 4 hrs prior to the assay.  ** P ≤ 0.01 by 
one-way ANOVA and Tukey’s multiple comparison post-test, n = 3. 
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3.2 Oxidation of Pin1 modifies cysteine thiol groups. 
Cysteine 113 of Pin1 has previously been implicated in catalysis, and is 
predicted to be ionized at physiological pH due to its low predicted pKa.10  Low 
pKa cysteine is generally a target of oxidation from a variety of sources, including 
hydrogen peroxide.54-57  The thiol sidechain of cysteine is susceptible to oxidative 
modification by H2O2 to sulfenic, sulfinic, and sulfonic acid – the addition of one, 
two, or three oxygen molecules to the sulfur, respectively68  In order to determine 
whether the thiol of Cys113 is modified during oxidation-mediated inhibition of 
Pin1, a cysteine-counting reagent, 4’4’-dithiodipyridine (DTDP), was used to 
spectrophotometrically monitor the loss of unmodified thiols while inhibiting 
Pin1 with H2O2.59  Though Pin1 has two cysteine residues at positions 57 and 113, 
Cys57 is not solvent-accessible in either of two representative crystal structures 
(1PIN or 1F8A) as determined by the European Bioinformatics Institute’s 
macromolecular interface software suite, PDBePISA.3,67,69  It was therefore 
expected that only Cys113 would react with DTDP in the untreated sample, 
whereas the oxidized samples would show no reaction with DTDP.  As seen in 
Figure 3-2, untreated R14A Pin1 shows one reactive thiol group per Pin1 
molecule, consistent with the solvent accessibility analysis.  A mutant of R14A 
Pin1 was used as a negative control, in which Cys113 was substituted for aspartic 
acid (C113D Pin1).  Untreated R14A C113D Pin1 showed no reactive thiol 
groups per protein molecule.  Treatment of 20 µM R14A Pin1 with either 500 µM 
or 1 mM H2O2 for 4 hours, as above, lowered the availability of reactive thiol to 
levels not significantly different than the negative control (P = 0.6 and P ≥ 0.99 by 
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one-way ANOVA and Tukey’s multiple comparison post-test).  This implies that 
the solvent-exposed thiol group of Cys113 is modified by oxidation.  Since 
Cys113 is involved in catalysis, oxidative modification of this residue may 
directly affect Pin1 enzyme activity. 
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Figure 3-2.  Oxidation of Pin1 modifies cysteine side-chain thiol groups. 
  The effect of oxidation on the number of cysteine thiol groups available for 
reaction with 4,4'-dithiodipyridine (DTDP).59  As above, 20 µM Pin1 was pre-
incubated with 500 µM or 1 mM H2O2 for 4 hrs followed by incubation with 
DTDP for 5 minutes at room temperature.  Absorbance was measured at 324 nm, 
and after substracting relevant controls, concentration of reacted cysteine was 
determined using literature values for ∆ε324.  *** P ≤ 0.001 and **** P ≤ 0.0001 
by one-way ANOVA and Tukey’s multiple comparison post-test, n = 6. 
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3.3 Oxidation-mediated inhibition of Pin1 is dependent on Cys113. 
To determine whether the loss of isomerase activity due to oxidation of 
Pin1 is due to oxidation of Cys113, the isomerase activity assay shown in Figure 
3-1 was repeated using Pin1 with an aspartic acid substitution at Cys113.  C113D 
Pin1 has been shown to retain approximately 30% of wild-type catalytic 
activity,10 and aspartic acid is considerably less susceptible to hydrogen peroxide-
mediated oxidation than cysteine,70 so it was expected to retain activity after 
treatment.  As seen in Figure 3-3, the same oxidation treatments that caused 100-
fold inhibition of wild-type Pin1, 500 µM and 1 mM H2O2 for 4 hours, had no 
significant effect on the catalytic activity of the C113D mutant (P = 0.78 and P = 
0.61 by one-way ANOVA and Tukey’s multiple comparison post-test).  This 
suggests that oxidative modification of Cys113 is directly responsible for 
oxidation-mediated inhibition of Pin1, since mutation of that residue to a 
catalytically-active aspartic acid rescues Pin1 isomerase activity under identical 
oxidation conditions. 
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Figure 3-3.  Oxidation-mediated inhibition of Pin1 is dependent on Cys113. 
R14A C113D Pin1 isomerase activity was measured spectrophotometrically using 
succinyl-AEPF-p-nitroanaline as in Figure 3-1.  Activity of the C113D mutant of 
Pin1 has been shown to be approximately 30% of that of wild-type Pin1.10  As in 
Figure 3-1, 20 µM R14A C113D Pin1 was pre-incubated with 500 µM or 1 mM 
H2O2 for 4 hrs prior to the assay.  R14A C113D Pin1 isomerase activity was not 
significantly different after treatment with 500 µM or 1 mM H2O2.  R14A Pin1 
treated H2O2 from the same stock solution is shown as a positive control.  ** P ≤ 
0.01 by one-way ANOVA and Tukey’s multiple comparison post-test, n = 3. 
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3.4 Oxidation of Pin1 results in sulfinylation of Cys113. 
The structural modification of Cys113 by hydrogen peroxide was 
investigated using X-ray crystallography.  Crystals of reduced R14A Pin1 were 
grown in hanging drops in 2.10 M ammonium sulfate, 1% (v/v) poly(ethylene 
glycol) 400 (PEG400) and 100 mM HEPES at pH 7.8 and 4 °C.  After 3 days, 
crystals of the space group P3121 appeared.  The crystal diffracted to 2.03 Å, and 
the structure was solved by molecular replacement using the published Pin1 
structure 2ITK (with ligand deleted), which has the same space group and unit 
cell geometry.63  The structure of reduced R14A Pin1 was very similar to 
published structures, with an RMSD of 0.180 Å when aligned to the Pin1 
structure 2ITK.  See Table 3-1 for structure statistics. 
In order to obtain structures of oxidized Pin1, crystals were grown as 
above with various concentrations of H2O2.  The largest crystal formed in 2.4 M 
ammonium sulfate, 1% PEG400, and 10 mM H2O2 after 3 days, and was also of 
the P3121 space group.  The crystal diffracted to 1.86 Å, and the structure was 
solved using molecular replacement with the reduced R14A Pin1 structure above.  
Overall, the structure was very similar to the reduced R14A Pin1 structure, with 
an RMSD after alignment of 0.137 Å.   
In order to determine whether the protein structure of the oxidized crystal 
contained any oxidative modifications, the observed electron densities of the 
untreated and oxidized crystals were compared using an isomorphous difference 
map of |Fo(oxidized)|-|Fo(untreated)| (Figure 3-4a).  Both of the largest positive 
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and negative differences centered around Cys113, at 10.06 and -6.32 sigma, 
respectively.  The crescent-shaped “ripples” of positive and negative differences 
in electron density indicate a difference in positioning between the atoms in the 
two structures, while the larger peak of positive density versus the surrounding 
negative density suggests a difference in occupancy, specifically that the oxidized 
structure has higher electron occupancy in that area.  Overlaying the refined 
model from oxidized Pin1 crystal shows the positioning difference between 
Cys113 in each crystal, and that this slight torsion of the oxidized structure is 
localized to Cys113 and Ser114, with an RMSD between these pairs of residues 
of 0.49 Å (Figure 3-4b). 
Refinement of the oxidized crystal structure resulted in further evidence of 
a modification at Cys113.  By comparing the 2|Fo|-|Fc| maps from the refined 
structures of untreated R14A Pin1 (Figure 3-5a) and R14A Pin1 crystallized in 
10 mM H2O2 (Figure 3-5b), the differences highlighted in the |Fo|-|Fo| map can be 
seen.  While electron density around the γ sulfur of the cysteine side chain of the 
untreated structure is larger than that of the β carbon, as expected for the larger 
sulfur atom, the oxidized structure has a much larger, pyramidal density.  The |Fo|-
|Fc| map shows a bi-lobed region of positive density around the two corners of the 
pyramidal shape not occupied by the sulfur of the model.  Since cysteine sulfinic 
acid is a product of cysteine oxidation, and the two oxygen atoms bound to the 
sulfur of the sulfinic acid form a pyramidal geometry, cysteine sulfinic acid was 
modelled into this site. As seen in Figure 3-5c, the resulting refined structure 
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showed no electron density unaccounted for in the |Fo|-|Fc| map around the sulfinic 
acid.   
Cysteine and methionine are the two amino acids most susceptible to 
oxidation by hydrogen peroxide.  However, none of the other cysteine or 
methionine residues in the refined Pin1 structure from the oxidized crystal 
showed excess density in the |Fo|-|Fc| map, suggesting that Cys113 is the most 
susceptible to oxidation (Figure 3-6a-d).  Furthermore, as noted above, the two 
structures of Pin1 overlay almost perfectly, with an RMSD of 0.137 Å, with only 
the termini of each domain, and the Cys113 and Ser114 regions showing changes 
in backbone position (Figure 3-6e).   
The specific oxidation of Cys113 to irreversible cysteine sulfinic acid 
shown in this crystal structure suggests that this residue is most readily oxidized, 
and this modification directly results in the inhibition of Pin1. 
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Table 3-1.  Crystallographic 
data collection and refinement  Untreated R14A Pin1 
R14A Pin1 
+ 10 mM H2O2 
Resolution range (Å) 
47.55 - 2.042 
(2.115 - 2.042) 
29.62 - 1.863 
(1.929 - 1.863) 
Space group P3121 P3121 
Unit cell 
68.65 68.65 79.23 
90 90 120 
68.4 68.4 79.29 
90 90 120 
Total reflections 26098 (2060) 35843 (3197) 
Unique reflections 13691 (1143) 18247 (1653) 
Multiplicity 1.9 (1.8) 2.0 (1.9) 
Completeness (%) 96.83 (83.13) 99.04 (90.87) 
Mean I/sigma(I) 9.64 (2.13) 21.13 (6.03) 
Wilson B-factor 25.83 20.53 
R-merge 0.04061 (0.3017) 0.02349 (0.1144) 
R-meas 0.05743 0.03322 
R-work 0.1953 (0.2847) 0.1767 (0.2267) 
R-free 0.2453 (0.3752) 0.2102 (0.2580) 
Number of atoms 2529 2517 
  macromolecules 1155 1157 
  ligands 24 24 
  water 190 181 
Protein residues 145 145 
RMS(bonds) 0.012 0.011 
RMS(angles) 1.31 1.27 
Ramachandran favored 98% 97% 
Ramachandran outliers 0.71% 0.71% 
Clash score 6.14 3.07 
Average B-factor 26.1 26.2 
  macromolecules 24.8 25 
  ligands 28 19.4 
  solvent 34.4 35 
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Figure 3-4.  Difference maps of the untreated and oxidized R14A Pin1 crystals. 
(A) Crystal structure of untreated R14A Pin1 at 2.04 Å with a 2|Fo|-|Fc| map (blue) 
contoured at 1.0 sigma, and an |Fo|-|Fo| map (green/red) contoured at 3.0 sigma.  
The two highest magnitude peaks were 10.06 and -6.32 sigma, and are shown as 
labelled grey stars.  (B) As above, with R14A Pin1 crystallized with 10 mM H2O2
 
at 1.86 Å (light grey and pink backbone) aligned with untreated R14A Pin1 (dark 
grey and cyan backbone).  Images were created using The PyMOL Molecular 
Graphics System, Version 1.6.0.0 Schrödinger, LLC. 
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Figure 3-5.  Crystal structures of untreated and oxidized R14A Pin1. 
(A) The untreated R14A Pin1 crystal structure at 2.04 Å with a 2|Fo|-|Fc| map 
(blue) contoured at 1.0 sigma, and |Fo|-|Fc| maps (green/red) contoured at 3.0 
sigma.  The Cys113 residue from Pin1 crystallized in the absence of H2O2, 
showing an electron density typical of a sulfur atom, with no unmodelled density.  
(B) The crystal structure of R14A Pin1 crystallized with 10 mM H2O2
 
at 1.86 Å 
with a 2|Fo|-|Fc| map (blue) contoured at 1.0 sigma, and |Fo|-|Fc| maps (green/red) 
contoured at 3.0 sigma.  The Cys113 sulfur of Pin1 crystallized in the presence of 
10mM H2O2 shows extra electron density in a bi-lobed shape, suggesting two 
extra atoms bound to the cysteine sulfur.  (C) After addition of cysteine sulfinic 
acid at position 113, refinement of the oxidized Pin1 structure showed no electron 
density unaccounted for in the |Fo|-|Fc| map around position 113.  Images were 
created using The PyMOL Molecular Graphics System, Version 1.6.0.0 
Schrödinger, LLC. 
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Figure 3-6.  Oxidative modification of Pin1 is specific to Cys113. 
Cysteine and methionine are the two amino acids most susceptible to oxidation by 
H2O2.  Met15 (A), Cys57 (B), Met130 (C), and Met146 (D) show no positive 
electron density in the |Fo|-|Fc| map.  (E) An overlay of the untreated R14A Pin1 
structure and structure of R14A Pin1 crystallized in the presence of 10 mM  H2O2, 
with an RMSD of 0.137 Å.  The side chain of the cysteine sulfinic acid is shown, 
and the surface is coloured according to temperature factor of the oxidized 
structure.  Images were created using The PyMOL Molecular Graphics System, 
Version 1.6.0.0 Schrödinger, LLC. 
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3.5 Hydrogen peroxide treatment of Pin1 for isomerase assays 
parallels treatment of Pin1 crystals. 
The concentration of hydrogen peroxide used to oxidize R14A Pin1 in 
crystals was necessarily lower than that used in in vitro assays, since the 
timeframe of exposure was days instead of hours.  This makes it difficult to draw 
parallels between the in vitro isomerase data and the crystal structure.  In order to 
assess the structural modifications to R14A Pin1 resulting from the in vitro H2O2 
treatment, ESI mass spectrometry was used to accurately measure intact protein 
mass.  R14A Pin1 was oxidized by 1 mM H2O2 for 4 hours as in the isomerase 
assays above, and analysed using Q-TOF ESI mass spectrometry.  The resulting 
data (red trace) was compared to data from analysis of untreated R14A Pin1 
(black trace), as seen in Figure 3-7a.  The peak corresponding to R14A Pin1 
shifted 32 Da after treatment.  This mass is corresponds to two oxygen molecules, 
which is consistent with the oxidative modification of Cys113 to cysteine sulfinic 
acid as seen in the crystal structure.  This indicates that the H2O2 treatments used 
in crystal formation and in in vitro assays have the same structural effects. 
Cysteine sulfinic acid is a chemically-irreversible oxidative modification 
of cysteine, while the less stable cysteine sulfenic acid can be reduced back to 
cysteine by a variety of reducing agents including dithiothreitol (DTT).71  In order 
to determine whether cysteine sulfenic acid or sulfinic acid is the cause of the 
inhibition seen in vitro, the isomerase assay from Figure 3-1 was repeated after 
attempting to reverse the inhibition by exposure to DTT.  As above, 20 µM Pin1 
was incubated with 1 mM H2O2 for 4 hours at 4 °C, then the H2O2 was 
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decomposed by adding 400 units of catalase at room temperature for 15 minutes, 
followed by 10 mM DTT for 30 minutes.  The isomerase assay showed no 
significant rescue of catalytic activity of Pin1 after treatment with DTT (P = 0.93 
by one-way ANOVA and Tukey’s multiple comparison post-test), as seen in 
Figure 3-7b.  Therefore the H2O2 treatment resulting in the in vitro inhibition of 
Pin1 for these isomerase assays is causing irreversible oxidation of Cys113 to 
sulfinic acid, as shown in the crystal structure above. 
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Figure 3-7.  H2O2 treatment of Pin1 for isomerase assays parallels crystal 
structure treatment. 
(A) ESI mass spectrometry analysis of untreated R14A Pin1 (black trace) and 
R14A Pin1 treated with 1 mM H2O2 for 4 hours (red trace), as in Figure 3-1.  
Recombinant R14A Pin1 shows one major peak at 17583 Da, and upon oxidation, 
that peak shifts 32 Da to 17615 Da.  This mass change corresponds to the two 
additional oxygen molecules of cysteine sulfinic acid, as shown in Figure 3-5c.  
(B) Isomerase activity of R14A Pin1 as in Figure 3-1.  20 µM Pin1 was pre-
incubated with 1 mM H2O2 for 4 hrs, then quenched by adding 400 U of catalase 
for 15 minutes, followed by 10 mM DTT for 30 minutes.  Treatment with DTT 
showed no significant increase in activity compared to the oxidized sample (P > 
0.5 by one-way ANOVA and Tukey’s multiple comparison post-test), while all 
treatments showed significantly reduced activity compared to the untreated 
sample, which suggests that Cys113 is irreversibly oxidized to cysteine sulfinic 
acid with this treatment.  ** P ≤ 0.01 by one-way ANOVA and Tukey’s multiple 
comparison post-test, n = 3. 
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3.6 Oxidation-mediated inhibition of Pin1 is reversible. 
An interesting result appeared in the process of ensuring that the hydrogen 
peroxide treatment used in the in vitro activity assays resulted in the same 
oxidative modification as seen in the crystal structure.  When performing the 
isomerase assays on R14A Pin1 pretreated with 500 µM H2O2, it was found that 
contrary to the results above, treating with 10 mM DTT for 30 minutes rescued 
30% of isomerase activity relative to untreated R14A Pin1.  This suggested that 
30% of Cys113 residues in the Pin1 sample were not being oxidized to sulfinic 
acid, but rather to its unstable reducible precursor, sulfenic acid.  This is an 
interesting finding, as it opens the door to the possibility of regulation of Pin1 
isomerase activity by physiological redox mechanisms.  To investigate this 
further, it was hypothesized that with shorter durations of H2O2 treatment, a larger 
percentage of Cys113 in the Pin1 sample would be oxidized to sulfenic acid, 
thereby inhibiting Pin1 activity, but allowing for rescue of activity after reduction 
with DTT.  Figure 3-8a shows that partial rescue of Pin1 isomerase activity was 
possible by reducing the duration or concentration of hydrogen peroxide 
treatment.  Similar to above, Pin1 was treated for 4 hours or less with 500 µM 
H2O2, or 1 hour or less of 1 mM H2O2, then H2O2 was decomposed by adding 
catalase.  This was followed by 30 minutes of 10 mM DTT treatment, after which 
isomerase assays showed that treated samples had 30-45% of activity relative to 
untreated R14A Pin1.  This result suggests that the less stable, reducible oxidation 
product of cysteine, sulfenic acid, is forming at lower H2O2 treatments, albeit not 
universally.  
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It is also notable that for a specific subset of conditions, varying the 
duration or concentration of H2O2 treatment has no effect on the degree of DTT-
mediated rescue.  Efficacy of rescue did not vary more than 15% for treatments 
between 30 minutes and 4 hours at 500 µM H2O2, or between 30 mintues and 1 
hour at 1 mM H2O2.  Linear regression analysis of those data plotted as a function 
of activity versus exposure time showed that the slope of the resulting line was 
not significantly deviated from zero (P = 0.87), implying that exposure time had 
no significant effect on rescue, over that time frame.  By looking at the graph in 
Figure 3-8a, it appears as though the efficacy of rescue drops in a stepwise rather 
than linear manner as concentration and duration of H2O2 treatment increases.   
To assess the validity of the observation that there are discrete differences 
in the response of Pin1 to varying treatments of hydrogen peroxide, rather than a 
continuous linear trend, K-means clustering analysis was used.65  K-means 
clustering is a simple unsupervised machine learning algorithm that attempts to 
group data based only on its proximity to each cluster’s centroid.  The algorithm 
works by iteratively assigning a centroid values for each putative cluster, then 
partitioning the data to minimize the within-cluster sum of squares (a measure of 
distance between the centroid and each data point assigned to it), until optimal 
positions of centroids and partitioning of data has been achieved. 
As shown in Figure 3-8b, K-means clustering of the data from Figure 3-
8a, plotted as isomerase activity versus H2O2 concentration versus duration of 
treatment separated the data into three groups: fully active (in purple), partially 
active (in cyan), and inactive (in red).  All samples treated with H2O2, but not 
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DTT, were labelled as inactive, while the untreated samples were labelled as fully 
active.  All samples treated with both H2O2 and DTT, except those treated with 1 
mM H2O2 for 2 and 4 hours clustered together as partially active, meaning that 
their activities were nearer to each other than the activities of the fully active or 
inactive samples.  The clusters were significantly different by one-way ANOVA 
and Tukey’s multiple comparison post-test (P < 0.0001).  The information from 
these two analyses suggests that the Pin1 sample has discrete responses to varying 
levels of oxidative stress.  At a certain threshold concentration and duration of 
H2O2 exposure, in this case between 1-2 hours at 1 mM H2O2, the whole Pin1 
sample population is irreversibly oxidized, suggesting that in all molecules 
Cys113 is modified to cysteine sulfinic acid.  Whereas below that threshold (less 
than 1 hour at 1 mM H2O2, or 4 hours or less at 500 µM H2O2) 30-45% of Cys113 
in the Pin1 sample is oxidized but reducible, suggesting that it is modified to 
cysteine sulfenic acid.  While further investigation of the significance of discrete 
nature the response of Pin1 to oxidation, it is apparent that Pin1 isomerase activity 
may be reversibly regulated by oxidation. 
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Figure 3-8.  Inhibition of Pin1 by oxidation is partially reversible. 
Isomerase activity of R14A Pin1 as in Figure 3-1, with DTT treatments as in 
Figure 3-7.  20 µM Pin1 was pre-incubated with 500 µM or 1 mM H2O2 for up to 
4 hrs, then quenched by adding 400 U of catalase for 15 minutes, followed by 10 
mM DTT for 30 minutes.  (A) DTT treatment had a significant effect on all 
oxidation treatments except for the untreated control, and treatments of 1 mM of 
H2O2 for 2 or 4 hours.  * P ≤ 0.05 by paired T-tests, n = 3.  (B) K-means 
clustering analysis of the above data 65.  ● is without DTT, and ■ is those treated 
with 10 mM DTT.  The colours represent the clusters assigned by the K-means 
algorithm, with fully active in purple, partially active in cyan, and inactive in red.  
The clusters were significantly different by one-way ANOVA and Tukey’s 
multiple comparison post-test (P < 0.0001). 
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4 Discussion 
4.1 Pin1 in neurodegeneration. 
The peptidyl-prolyl isomerase Pin1 has diverse roles in a number of 
human diseases, and is consequently of interest to the field of medical research.  
In cancer, its role in proliferation makes it a potential therapeutic target, while in 
dementias, its ability to reverse some of the neurodegenerative pathologies is of 
interest.72  Given that Pin1 has been shown to be neuroprotective, an effort has 
been made to understand why it cannot effectively perform that role in 
neurodegenerative diseases such as Alzheimer’s disease (AD).  While there is 
little evidence to suggest that there is a genetic link, or that Pin1 expression 
changes in AD 38-42, it has been shown that Pin1 availability and subcellular 
localization is negatively affected by AD pathologies.  Pin1 associates with both 
neurofibrillary tangles and amyloid plaques in AD neurons, and this causes a 
reduction in the soluble fraction of Pin1, and a change in localization from the 
nucleus to cytoplasm.30,31,43,44  Since Pin1 has been shown to prevent or reverse 
both of these pathologies, there must be another mechanism by which Pin1 
activity is lost prior to AD onset.23,27 
  A series of oxidative proteomics studies of Mild Cognitive Impairment 
(MCI)46 and AD47 brain tissue by the Butterfield lab demonstrated that Pin1 is 
significantly oxidized in aging brain and this oxidation negatively impacts Pin1 
enzymatic activity..  In both MCI and AD hippocampal samples, Pin1 was shown 
to have lower activity than in age-matched controls, and by treating purified Pin1 
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with hydrogen peroxide in vitro, it was shown that loss of isomerase activity 
could be attributed to oxidation.  These studies established a role for Pin1 in the 
progression of Alzheimer's disease; the neuroprotective functions of Pin1 are lost 
as age-related oxidative stress inhibits Pin1, allowing the formation of 
neurofibrillary tangles and B-amyloid deposits which accelerate the loss of Pin1 
function by sequestering it to the insoluble fraction.  In order to prevent or reverse 
this pathological loss of Pin1 activity, it is necessary to determine the biochemical 
mechanism of Pin1 inhibition by oxidation. 
 
4.2 Pin1 is inhibited by oxidation. 
To elucidate the biochemical mechanism of oxidation-mediated inhibition 
of Pin1, it was first necessary to determine the in vitro conditions in which Pin1 is 
effectively inhibited by oxidation.  One of the Butterfield group’s studies assayed 
oxidation-mediated inhibition of Pin1 isomerase activity in vitro.  In their study, 
55 nM of purified Pin1 was treated with 1 mM H2O2 for 3 hours, resulting in 60% 
activity versus the untreated sample.47  As shown in Figure 3-1, purified R14A 
Pin1 was treated with either 500 µM or 1 mM H2O2 for 4 hours at 4 ºC, which 
resulted almost complete loss of activity (2% activity versus the untreated 
sample).  Reducing the length of H2O2 exposure to 2 hours did not change the 
extent of inhibition, as seen in Figure 3-8a.  In principle these results are 
consistent with the findings of the Butterfield group, both show that Pin1 is 
inhibited by oxidation.  However, the difference between the modest reported 
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inhibition in their study and the robust inhibition shown here may be due to 
limitations inherent in the methodology used to determining isomerase activity. 
The chymotrypsin-linked spectrophotometric assay of isomerase activity 
used in both this study and previous studies of Pin1 oxidation was first developed 
by Fischer et al. in 1984, with the critical finding that chymotrypsin cleaves 
proline-containing substrates in an isomer-specific manner, therefore allowing the 
amount of cis to trans isomerization of a substrate to be monitored.73  Kofron et 
al. furthered the assay by addressing the complication of non-enzymatic 
isomerization of the substrate.66  As the population of trans isomer of the 
substrate is consumed, an event termed the “burst phase”, non-enzymatic 
isomerization of the substrate occurs in order to redress the shift in isomer 
distribution from equilibrium.  Since any trans substrate subsequently produced is 
rapidly cleaved by chymotrypsin, this non-enzymatic isomerization rate remains 
steady, until all substrate is consumed.  Kofron et al. ran a series of control 
experiments to determine the first-order rate constant for this isomerization, in 
order to account for this when calculating PPIase dependent isomerization rates.  
Given that the substrates they used were optimized for chymotrypsin cleavage, 
and the concentration of chymotrypsin in the assay was high, the product of the 
isomerization reaction was assumed to be immediately cleaved by chymotrypsin.  
This allowed the rate of PPIase-mediated isomerization to be calculated from each 
absorbance progress curve using the integrated rate equation derived by Kofron et 
al., which included the rate constant of non-enzymatic isomerization. 
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In order to have enough data to fit to this model, Kofron et al. recognized 
the need to increase the relative concentration of substrate with cis-proline.  Their 
other major contribution to the development of this assay, therefore, was to 
develop a non-aqueous buffer that shifts the cis-trans equilibrium of the substrate 
such that up to 60% of substrate is in the cis isomer.  The buffer, consisting of 
lithium chloride dissolved in trifluoroethanol (LiCl/TFE), not only meant that the 
absorbance progress curve better fit the integrated rate equation, but also allowed 
for assaying with wider range of substrate concentrations.  Consequently, the 
assay could be used to fit Michaelis-Menten models of inhibition, as well as 
simple kinetics.66 
The isomerase assay was further modified by Behrsin et al. in 2007 to 
better control for the non-enzymatic isomerization rate, and address the concern 
that significant proteolysis of Pin1 over the course of the assay could affect 
results.10  That study controlled for non-enzymatic isomerization of the substrate 
internally during each experimental run by monitoring the absorbance change due 
to the initial burst of trans-substrate cleavage, and subsequent steady rate of 
isomerization prior to adding Pin1 to the system.  This can be seen in Figure 4-
1a, a sample trace from the current study, which uses the same methodology as 
Behrsin et al.  At position 1, the substrate in LiCl/TFE has just been added to the 
aqueous assay buffer in the spectrophotometric cuvette.  After gathering baseline 
absorbance data, chymotrypsin is added (position 2).  The “burst phase”, in which 
chymotrypsin rapidly cleaves all trans substrate, is clearly visible, followed by a 
steady-state rate of non-enzymatic isomerization.  After this steady state has been 
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achieved, Pin1 is added to the cuvette (position 3), and the isomerization rate 
from this point forward is a combination of Pin1-mediated and non-enzymatic 
isomerization of substrate, which is monitored until all substrate has been 
consumed in order to accurately calculate the initial concentration of cis peptide. 
In order to shorten run times, thereby reducing the impact of proteolysis 
on the results, Behrsin et al. opted not to use the integrated rate equation from 
Kofron et al. to determine isomerization rate from the absorbance progress curve 
of each run.  The integrated rate equation was used to account for the changing 
ratio of non-enzymatic contribution to the substrate isomerization rate as substrate 
is consumed.  By using only the linear portions of the absorbance progress curves, 
specifically the boxed region of Figure 4-1a, corresponding to the steady-state rate 
of non-enzymatic isomerization and the initial combined rates of Pin1-mediated 
and non-enzymatic isomerization, Behrsin et al. eliminated the need for the 
integrated rate equation by simply subtracting the slope of one linear section from 
the other, as in Figure 4-1b.  The slope of the blue line represents the rate of non-
enzymatic isomerization, while the slope of the orange line represents the initial 
rate of Pin1-mediated isomerization combined with the rate of non-enzymatic 
isomerization.  By subtracting these values, the initial rate of Pin1-mediated 
isomerization ( 0v ) is determined.  By determining 0v  at a number of substrate 
concentrations in which [cis-substrate] ᴅ KM, the resulting [cis-substrate] vs. 0v  
plot can be fit to the linear reduction of the Michaelis-Menten equation: 
][][ 00 SEK
k
v
M
cat
= , as seen in Figure 4-1c. 
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Figure 4-1.  An sample response curve for the spectrophotometric isomerase 
assay. 
(A) The response curve in its entirety.  Before beginning, the appropriate 
concentration of succinyl-AEPF-p-nitroanaline is added to the buffer solution in 
the cuvette.  1. Data collection begins in order to get a baseline value for 
determination of the total substrate concentration.  2. Chymotrypsin is added, and 
immediately begins cleavage of trans substrate, releasing p-nitroanaline and 
causing an increase in absorbance at 410 nm.  Once chymotrypsin has cleaved all 
available trans peptide, the absorbance curve levels off, though the slope remains 
positive, representing the rate of chemical isomerization of the peptide.  3. Pin1 is 
added after the curve has become linear.  During the period of time in which Pin1 
is saturated by substrate, the slope of the absorbance curve is linear, and 
represents the sum of the rates of chemical and Pin1-catalysed isomerization.  As 
Pin1 and chymotrypsin consume substrate, the absorbance curve levels off until 
all substrate is consumed.  The absorbance at 3 is subtracted from this absorbance 
to determine the concentration of peptide when Pin1 was added.  (B) This figure 
is the boxed section of the response curve from (A).  The slopes of the blue and 
orange lines represent the chemical and chemical + Pin1-mediated isomerization 
rates, respectively.  The former is subtracted from the latter to determine the Pin1-
catalyzed isomerization rate.  (C) The Pin1 isomerization rate is determined at a 
number of substrate concentrations, and these data are plotted as Pin1 
isomerization rate (mM/s) versus substrate concentration (mM).  The resulting 
slope (s-1) is divided by the concentration of Pin1 to determine the Kcat/Km (mM-
1s-1). 
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The critical difference between the results of this study and those of the 
Butterfield lab is that while the latter showed a reduction in Pin1 isomerase 
activity to 60% of the untreated control, almost identical treatments of hydrogen 
peroxide yielded 2% isomerase activity in the current study.  The Butterfield lab 
cites Kofron et al.66 and Schutkowski et al.74 as sources for their PPIase assay 
technique, while Schutkowski et al. cite Fischer et al.73 as the source of their 
assay.47  Based on this, one could assume that they used substrate peptides 
dissolved in LiCl/TFE, ran a chymotrypsin-only control, and used the integrated 
rate equation to account for the contribution of non-enzymatic isomerization to 
the change in absorbance monitored by the assay.  However, while the isomerase 
assay is only briefly outlined in their methods, it is noted that the substrate peptide 
was dissolved in DMSO.  Kofron et al. showed that the ratio of cis isomer in 
peptides dissolved in DMSO was approximately 10%,66 whereas in their 
LiCl/TFE buffer that climbed to 40-60%.  The increase in the dynamic range of 
the absorbance progress curve afforded by the higher proportion of cis isomer in 
substrates dissolved in LiCl/TFE allowed Kofron et al. to determine 0v  using the 
integrated rate equation, thereby appropriately controlling for non-enzymatic 
isomerization in their assay.  The Butterfield lab studies mention neither avoiding 
collecting the “burst phase” in the absorbance progress curve, as in Kofron et al., 
nor addressing the contribution of steady-state non-enzymatic isomerization of 
substrate to the apparent activity displayed in their assay’s absorbance progress 
 57 
 
curve.  While the steady-state non-enzymatic isomerization rate may be relatively 
low compared to untreated Pin1-mediated isomerization rates, the “burst phase” 
in the absorbance progress curve is not, as seen in Figure 4-1a after position 2.  
Since the isomerase assay used by the Butterfield group does not temporally 
separate this “burst phase” from monitoring the change in absorbance due to Pin1-
mediated isomerization, as done in Behrsin et al.,10 there is a risk that this may 
have affected the calculation of the Pin1-mediated isomerization rate in that assay.  
It is therefore possible that the lack of inhibition due to oxidation seen by the 
Butterfield group is due to overlooked non-enzymatic isomerization of the 
substrate. 
If this is the case, the finding that Pin1 is inhibited by oxidation impacts a 
variety of neurodegenerative diseases.  Using the same isomerase assay, the 
Butterfield lab also showed that in the hippocampus of AD patients’ brains, Pin1 
activity was approximately 60% compared to that of age-matched controls.47  The 
same lab also showed that Pin1 in hippocampal homogenates of MCI patients was 
shown to have 90% activity compared to age-matched normal hippocampal 
samples.46  Given that the assay used in these experiments underestimates the 
degree of inhibition of isomerase activity, this indicates that the oxidation-
mediated inhibition of Pin1 shown in vitro in this study is paralleled in 
neurodegenerative disease.  In order for this information to be of therapeutic 
value, however, it is important to understand the molecular cause of this 
inhibition. 
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4.3 Oxidation of Pin1 modifies cysteine thiol groups. 
A common mechanism for redox regulation of proteins is through 
modification of a thiol group, especially that of a cysteine residue with a low 
pKa.54-57,71  While this commonly results in disulfide formation, recent studies 
have shown that oxidative modification of active-site cysteine residues can result 
in the formation of other oxidation products, and consequently modify protein 
activity.55,75,76  In order to determine whether cysteine thiol groups of Pin1 are 
modified by oxidation, a simple method used to count cysteine thiol groups was 
used.  The reagent 4’4’-dithiodipyridine (DTDP) behaves similarly to Ellman’s 
reagent in that it reacts with cysteine thiols to release a chromophore that can be 
monitored spectrophotometrically.59  The concentration of the reaction product, 4-
thiopyridone, which has maximal absorbance at 324 nm, is directly correlated to 
the concentration of unmodified cysteine in solution.  By comparing this to the 
concentration of protein in solution, a count of unmodified cysteine residues per 
protein molecule can be calculated.  As seen in Figure 3-2, untreated R14A 
C113D Pin1 (negative control) contains no solvent-exposed cysteine residues, 
while untreated R14A Pin1 (positive control) has one.  While Pin1 has two 
cysteine residues, Cys57 and Cys113, Cys57 is buried in the properly folded 
protein.3,67  Therefore it was expected that R14A C113D Pin1 shows no reactivity 
with DTDP, since it only contains Cys57, while R14A Pin1 has one solvent-
exposed thiol on Cys113.  Treatment with hydrogen peroxide significantly 
decreased the availability of reactive thiols on R14A Pin1 to levels not 
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significantly different than the negative control.  Therefore oxidation is modifying 
the thiol group of Cys113 of Pin1. 
 
4.4 Oxidation-mediated inhibition of Pin1 is dependent on Cys113. 
Cys113 of Pin1 is located in the active site of the isomerase domain, and 
has been implicated in catalysis.  Early structural studies proposed a nucleophilic 
role for this residue, similar to that of a cysteine protease.3  It was proposed that 
the nearby His59 deprotonates Cys113, resulting in nucleophilic attack by the 
thiolate on the carbonyl carbon of the substrate.  The resulting high-energy 
tetrahedral intermediate would then be released, potentially changing its isomeric 
conformation.  Subsequent studies, however, demonstrated that a covalent 
interaction between Pin1 and its substrates was unlikely.  First, solution NMR 
studies of a Pin1 homolog showed none of the chemical shifts expected for 
covalent interaction when incubated with a substrate.77  Secondly, mutational 
analysis identified a catalytically active Pin1 mutant containing an aspartic acid 
substitution at position 113, as well as a conserved hydrogen-bonding network 
around Cys113.10,78  These studies instead reinforced an alternative theory, which 
proposes that Pin1 catalyzes isomerization of the peptide bond by placing the 
substrate carbonyl oxygen in a negatively charged environment, weakening the 
double-bond character of the peptide bond and allowing it to rotate.  Though the 
literature is still divided between these two mechanisms, it is apparent that 
Cys113 is both physically near to substrates and chemically important to their 
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Pin1-catalyzed isomerization.  It is therefore likely that oxidation-mediated 
inhibition of Pin1 involves this cysteine thiol. 
In order to determine whether oxidation-mediated inhibition of Pin1 is 
dependent on oxidation of Cys113, isomerase assays were performed using a 
recombinant Pin1 enzyme containing a catalytically active C113D mutation 
(R14A C113D Pin1).  While cysteine is susceptible to oxidation by hydrogen 
peroxide, aspartic acid is much more resistant to oxidative stress.  Oxidation of 
aspartic acid is generally caused by irradiation, and results in beta-scission of the 
side chain to form glyoxylic acid.70  If oxidation-mediated inhibition occurs due 
to modification of Cys113, it is predicted that isomerase activity of R14A C113D 
Pin1 will be unaffected by hydrogen peroxide.  As hypothesized, Figure 3-3 
shows that oxidation of R14A C113D Pin1 by H2O2 has no significant effect on 
isomerase activity.  This indicates that Cys113 is modified by oxidation, blocking 
its ability to participate in catalysis. 
 
4.5 Oxidation of Pin1 results in sulfinylation of Cys113. 
Oxidation of cysteine thiols can result in a wide variety of modifications 
with varying characteristics, as outlined in Figure 1-3.  Homodimerization via 
disulfide bonding is the classic example of biological oxidation of thiols.  The 
prototypical redox sensor in cells is glutathione (GSH), a tripeptide that forms a 
disulphide-linked homodimer upon oxidation.  GSH acts as a cellular redox 
buffer, as it is reduced by glutathione reductase and NADPH.71,79,80  
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Intermolecular disulfide bonding is also a common result of oxidation of thiols 
and plays a critical structural role in most secreted proteins.71,81  Intermolecular 
disulfide bond formation is also possible.  Despite the overall reducing 
environment of the cytoplasm, a number of proteins have been shown to 
reversibly cross-link via disulfide bonds in an H2O2-dependent manner, 
suggesting a role for disulfide bonding in H2O2-mediated signalling.82  Other 
oxidative modifications of cysteine thiol groups have also been shown to regulate 
various enzymes.  Protein tyrosine phosphatases are a family of cysteine-
dependent phosphatases involved in a number of signaling mechanisms.  
Oxidation of the low pKa catalytic cysteine of protein tyrosine phosphatase PTP1b 
has been shown to regulate its activity in the insulin response signaling cascade.76  
Oxidation of this residue by hydrogen peroxide results in the formation of a 
reversible sulphenyl-amide bond with the backbone amine of the following 
residue and subsequent inhibition of phosphatase activity.  More recently, redox 
regulation of the family of ovarian tumor (OTU) deubiquitinases has been 
identified.75  These cysteine proteases are also inhibited by hydrogen peroxide, 
which reversibly oxidizes the low pKa catalytic cysteine to cysteine sulfenic acid.  
Even cysteine sulfinic acid, which is not chemically reducible, is found in redox 
regulation.  Sulfiredoxin is an enzyme that catalyzes the reduction of cysteine 
sulfinic acid in the antioxidant enzyme family of 2-Cys Peroxiredoxins, 
regenerating their ability to reduce hydrogen peroxide in cells.83  Finally, cysteine 
sulfonic acid is the result of further oxidation of sulfinic acid, and is also 
irreversible. 
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In order to determine how Cys113 of Pin1 is modified by oxidation, R14A 
Pin1 was co-crystallized with H2O2 and the presence of structural modifications to 
Cys113 were determined by comparison of the x-ray diffraction data with that of 
untreated R14A Pin1.  After solving the structure of untreated R14A Pin1 at 2.04 
Å, the electron density maps generated from the x-ray diffraction data of the 
untreated and H2O2-treated crystals were compared, as seen in Figure 3-4a.  This 
analysis subtracts the electron density map of the oxidized crystal from that of the 
untreated crystal.  If the structures were identical, there would be very little 
differences in electron density, which are shown in green (positive density, 
attributable to the oxidized protein) and red (negative density, from the untreated 
protein).  The majority of the protein structure shows no difference in electron 
density, while highest magnitude peaks in both positive and negative difference 
maps occur around Cys113 suggesting that this residue is different in the oxidized 
structure.  Interpretation of the pattern of positive and negative densities in the 
difference map indicates two things: that the γ-sulfur of Cys113 is not aligned in 
the two structures, and that there may be extra electron density associated with it 
in the oxidized structure.  Initial refinement of the oxidized structure reinforced 
the former conclusion.  Overall, the two structures aligned very well after 
refinement, with an RMSD of 0.137 Å, but Cys113 and Ser114 were shifted 
slightly in the oxidized structure (local RMSD of 0.49 Å) to allow the γ-sulfur of 
Cys113 to move to the centre of the large positive density in the difference map.  
Consistent with the conclusions from the difference map, the |Fo|-|Fc| map used to 
assess the quality of the refined structure of oxidized Pin1 revealed positive 
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electron density around the γ-sulfur of Cys113, as shown in Figure 3-5b.  This 
map subtracts the electron density predicted by the modelled structure (Fc) from 
the electron density calculated from the x-ray diffraction data (Fo).  The positive 
map (in green) is the result of observed density not accounted for by the refined 
model.  In this case, the bi-lobular shape of the positive density suggests two 
atoms are bound to the γ-sulfur of Cys113.  Further refinement after replacing 
Cys113 with cysteine sulfinic acid showed that the two oxygen molecules account 
for this extra density and there is no unaccounted density around position 113 in 
the final refined structure. 
To determine whether oxidative modification of Pin1 is isolated to 
Cys113, the other susceptible sulfur-containing residues of Pin1 were investigated 
as above.  Both the difference map and the refined structures indicated neither the 
three solvent-exposed methionine residues nor the buried Cys57 were oxidized in 
the H2O2-treated crystal structure, as shown in Figure 3-6(a-d).  While the 
specificity of oxidative modification of Pin1 is impressive, it is not unexpected.  
The average predicted pKa of Cys113 in all Pin1 structures deposited in the 
Protein Data Bank (www.pdb.org) is at least two orders of magnitude lower than 
that of Cys57, and low pKa cysteines are generally the protein residues most 
susceptible to oxidation.71,84  As noted earlier, the local chemical environment 
causing the low pKa of Cys 113 is presumed to be necessary for catalysis, as it 
causes the cysteine thiol to carry a partial or full negative charge.  It would seem 
that susceptibility to oxidative stress is simply a by-product of that enzymatic 
mechanism. 
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4.6 Hydrogen peroxide treatment of Pin1 for isomerase assays 
parallels crystal structure treatment. 
In order to draw conclusions regarding the effects of oxidation on Pin1 
isomerase activity from the crystal structure of oxidized R14A Pin1, it was 
necessary to confirm that the hydrogen peroxide treatment used in co-
crystallization had the same structural effects as that used in the in vitro assays.  
Intact protein Q-TOF ESI mass spectrometry was used to accurately measure the 
mass change of Pin1 due to oxidation.  As seen in Figure 3-7a, the mass of R14A 
Pin1 increases by 32 daltons, which corresponds to two oxygen atoms, after the 
same H2O2 treatments used in vitro.  This would indicate that the in vitro H2O2 
treatment results in modification of Cys113 to cysteine sulfinic acid, as in the 
crystal structure.  This conclusion was confirmed by attempting to rescue 
isomerase activity of oxidized R14A Pin1 by reduction using dithiothreitol 
(DTT).  Figure 3-7b shows oxidation-mediated inhibition of R14A Pin1 by 1 mM 
H2O2 for 4 hours is irreversible.  Since cysteine sulfinic acid is not reducible, this 
result confirms that this H2O2 treatment results in oxidation of Cys 113 to cysteine 
sulfinic acid. 
 
4.7 Loss of Pin1 isomerase activity in neurodegenerative 
pathologies is due to oxidation of Cys113. 
Redox proteomics studies of the hippocampus of patients with Mild 
Cognitive Impairment (MCI) and Alzheimer’s disease (AD) have shown that Pin1 
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is oxidized in both of these conditions.46,47  These studies identified proteins as 
oxidized on the basis of the presence of peptide carbonyl derivatives.85  The 
generation of peptide carbonyl derivatives, or carbonylation, is generally the 
result of metal-catalysed oxidation or severe oxidation and can occur at most 
amino acids.70  The non-specific effects of carbonylation make it a convenient 
tool for redox proteomics studies, and also allow for comparison between the data 
from this in vitro study and the in vivo studies implicating oxidized Pin1 in 
neurodegenerative pathologies.  Since oxidative modification of cysteine to 
cysteine sulfinic acid requires less oxidative stress than the generation of peptide 
carbonyl derivatives, it follows that the Pin1 identified as carbonylated in MCI 
and AD hippocampal samples would contain oxidized Cys113.  This would imply 
that Pin1 from AD hippocampal samples should exhibit the same degree of 
oxidation-mediated inhibition demonstrated in the current study.  However, the 
studies of Pin1 oxidation in MCI46 and AD47 brain undertaken by the Butterfield 
lab show only modest inhibition by oxidation. One study even shows in vitro data 
that exhibits a similarly modest degree of Pin1 inhibition to the in vivo samples, 
despite using almost the same H2O2 treatment as in Figure 3-1, where isomerase 
activity is abolished by oxidation.47  Returning to the comparison of isomerase 
assay data between this study and those of the Butterfield lab, this is further 
evidence to suggest that the assay technique used in those studies underestimated 
the degree of inhibition due to oxidation.  The current study therefore reinforces 
the findings of the Butterfield group, that Pin1 is inactivated by oxidation in 
Alzheimer’s disease.  Furthermore, this study demonstrates that oxidation-
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mediated inhibition of Pin1 is caused by modification of Cys113 to cysteine 
sulfinic acid, a modification that requires a minimal degree of oxidative stress 
compared to carbonylation. 
MCI is considered a clinical precursor to symptomatic AD.45  Butterfield 
et al. identified Pin1 as carbonylated in MCI hippocampal samples, and showed 
that Pin1 isomerase activity in these samples was modestly reduced compared to 
age matched controls.46  As above, the findings of the current study suggest that 
the isomerase activity assay of Butterfield et al. underestimated the decrease in 
isomerase activity in the MCI samples.  These data suggest that Pin1 is inhibited 
by oxidation in the hippocampus of AD patients at or before the onset of their 
neurological symptoms, as defined by an MCI diagnosis. 
Adding the conclusions of this study to those of previous redox studies of 
Mild Cognitive Impairment and Alzheimer’s disease hippocampal tissue provides 
increased evidence for the validity of the model proposed at the beginning of this 
chapter.  As outlined in a recent review of the subject, an aging-related increase in 
oxidative stress causes the loss of Pin1 isomerase and thus a loss of the 
neuroprotective roles of Pin1, including the prevention of Alzheimer's pathologies 
such as B-amyloid deposition and the formation of neurofibrillary tangles.86  The 
implication of this work is that the inhibition of Pin1 isomerase activity caused by 
oxidation of Cys113 occurs prior to the onset of Alzheimer’s disease, and may 
play a role in its progression. 
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4.8 Oxidation-mediated inhibition of Pin1 is reversible. 
While the goal of this study was to explore the structural basis for the 
oxidation-mediated inhibition of Pin1 in Alzheimer’s disease, a serendipitous 
result revealed another interesting aspect of redox effects on Pin1.  While 
attempting to rescue Pin1 isomerase activity by reduction using dithiothreitol 
(DTT), it was noted that while treatment with 1 mM H2O2 for 4 hours results in 
irreversible oxidation, halving the concentration of H2O2 allows for modest 
rescue.  This effect was explored by varying the duration of H2O2 treatments, as 
shown in Figure 3-8a.  Even at 1 mM H2O2, shorter durations of treatment 
allowed for modest rescue of isomerase activity by reduction of Pin1.  However, 
once below the threshold required for irreversible inhibition, neither concentration 
of H2O2 nor duration of treatment changed the efficacy of rescue of isomerase 
activity.  This observation was confirmed by analyses that showed that there was 
no non-zero correlation between these inputs and the change in isomerase activity, 
and that the behaviour of Pin1 isomerase activity in response to the varying 
treatments clustered in discrete and significantly different groups corresponding 
to inactive, fully active, and partially active isomerase activity.  The latter group 
was composed entirely of data points from treatments including rescue by DTT.  
In order for Pin1 isomerase activity to be rescued by reduction of the oxidized 
Cys113, that residue must have been modified to the less stable cysteine sulfenic 
acid rather than sulfinic acid.  The fact that 30-45% of isomerase activity is 
rescued over a range of treatments suggests that a distinct and persistent subset of 
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Pin-1 sample population is able to maintain the unstable sulfenic acid moiety at 
Cys113, while the remaining molecules are further oxidized to sulfinic acid. 
It has been proposed that the hydroxyl of cysteine sulfenic acid must 
participate in hydrogen bonding in order to prevent further oxidation to 
irreversible sulfinic acid.75  Hydrogen peroxide-mediated oxidation of cysteine to 
sulfenic acid and subsequent oxidation reactions are essentially SN2 reactions 
requiring a nucleophilic thiolate or sulfenyl group.52,53  Hydrogen bond pairing 
between the sulfenic acid and a nearby hydrogen bond donor reduces the 
nucleophilicity of the sulfenyl, preventing further oxidation by H2O2.  Figure 4-
2a shows that the ovarian tumor deubiquitinase family stabilizes cysteine sulfenic 
acid in its catalytic pocket this way, thereby allowing these proteases to be 
regulated to hydrogen peroxide.  Pin1 and its evolutionarily ancient homologs 
maintain a complex hydrogen bonding network in the isomerase domain active 
site, as shown in Figure 4-2b.69,78  This hydrogen bonding network is essential to 
Pin1 function and has been hypothesized to maintain Cys113 in an ionized or 
partially charged state.10  A thiolate group on Cys113 does not have a proton 
available to accept a hydrogen bond from the carbonyl of the substrate peptide, 
allowing Cys113 to destabilize the carbonyl anion that occurs in the double-bond 
resonance state of the substrate peptide bond.  This hydrogen bonding network 
may also have the added effect of stabilizing the reversible cysteine sulfenic acid 
oxidation product of Cys113, allowing Pin1 isomerase activity to be reversibly 
regulated by oxidation. 
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If His59 is acting as a hydrogen bond donor to stabilize cysteine sulfenic 
acid in position 113 of oxidized Pin1, one would expect this effect to be uniform 
throughout the sample of Pin1, or at least affected in a linear fashion by the 
severity of oxidative stress in the system.  However, this study has shown that 
over a range of H2O2 treatments, a distinct and persistent subset of the Pin1 
population is capable of stabilizing cysteine sulfenic acid, while the remainder is 
not.  Assuming stability of sulfenic acid is dependent on hydrogen bonding, this 
suggests that only 30-45% of the ε2 nitrogen of His59, which is proximal to 
Cys113, is capable of acting as a hydrogen bond donor in these conditions.  
Histidine is a complex amino acid which exists in a number of pH dependent 
ionic and tautomeric states.  Li & Hong recently undertook a rigorous 
characterization of these states, and some of their structural characteristics.87  As 
shown in Figure 4-2c, the histidine tautomer in which Nε2 can act as a hydrogen 
bond donor exists only at high pH.  However, the average predicted pKa of His59 
in all Pin1 structures deposited in the Protein Data Bank (www.pdb.org) was 
approximately 3, whereas normally histidine has a pKa of approximately 7.84  This 
suggests that the equilibrium for the various states of histidine at this residue is 
shifted, allowing some of the His59 amino acids in the Pin1 population to adopt 
the π tautomer, thereby allowing Nε2 to serve as a hydrogen bond donor, and 
stabilizing sulfenic acid.   
This hypothesis seems inconsistent with the Pin1 enzyme model in which 
His59 Nε2 is a required hydrogen bond donor for maintaining a thiolate at Cys113 
to catalyze isomerization.  However, more recent structural studies have shown 
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that the dual-histidine motif in the Pin1 isomerase domain active site does not 
play a role in catalysis of isomerization.14  Recombinant Pin1 in which both His59 
and His157 were substituted with leucine (H59L/H157L Pin1) was capable of 
maintaining viability in yeast, where the isomerase activity of Pin1 or its yeast 
analogue Ess1 is necessary for viability.  The pKa of Cys113 was predicted to be 
unchanged by these mutations, suggesting that the anionic nature of Cys113 was 
unchanged and that it was sufficient for catalysis of isomerization.84  Thus the 
isomerase activity of Pin1 is not dependent on the tautomeric state of His59.  In 
that study, it was concluded that the dual histidine motif plays a structural role 
and may have a role in the dynamics of the Pin1 catalytic pocket.14  Since these 
two histidines are evolutionarily conserved,10 they must have some importance to 
the physiological functions of Pin1 yet that role is currently not convincingly 
characterized.  The current study has revealed that oxidation-mediated inhibition 
of Pin1 is reversible and that this reversibility may be dependent of the 
availability of His59 for hydrogen bonding.  The specificity of oxidative 
modification of the active-site Cys113, along the evolutionary conserved His59-
dependent reversibility of the subsequent inhibition, suggests that Pin1 may be 
physiologically regulated by hydrogen peroxide.  This would add Pin1-mediated 
signalling pathways to the emerging field of redox regulation, further reinforcing 
the need for a global survey of potential redox-regulated enzymes. 
 
 71 
 
 
 
 
A 
B 
C 
 72 
 
Figure 4-2.  Hydrogen bonds stabilize the cysteine sulfenic acid. 
(A) Hydrogen bonding to backbone amine and a nearby His stabilizes the cysteine 
sulfenic acid in OUT deubiquitinases.  Adapted from Kulathu et al., 2013 75.  (B) 
The network of hydrogen bonds in the Pin1 isomerase domain active site, shown 
in oxidized Pin1 containing cysteine sulfinic acid.  His59 and both the backbone 
amine and sidechain hydroxyl of of Ser115 can participate in hydrogen bonding 
with the Cys113 thiol group.  The extensive network is hypothesized to help 
maintain the Cys113 thiol in a partially or full negatively charged state 10.  Images 
were created using The PyMOL Molecular Graphics System, Version 1.6.0.0 
Schrödinger, LLC.  (C) The various ionic and tautomeric forms of histidine, and 
their equilibrium constants.  Adapted from Li and Hong, 2011 87. 
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4.9 Future considerations. 
In order to better understand the biochemical requirements for redox 
regulation of Pin1, dependence of this phenomenon on hydrogen bonding to 
His59 should be established.  In order to assess this, further isomerase activity 
rescue assays are needed to compare a His59-deficient mutant with wild-type 
Pin1, together with x-ray crystallography experiments to determine a structure for 
Pin1 with cysteine sulfenic acid.  Alternative modalities for Cys113-dependent 
redox regulation should also be explored, specifically the possibility of 
intermolecular disulfide bonding as a mechanism of Pin1 inhibition in cells.  
Finally, the effects of sulfenylation of Cys113 of Pin1-substrate interactions 
should be evaluated, using a previously established pulldown technique. 
Isomerase activity rescue assays using recombinant Pin1 proteins 
containing His59 mutations should be used to assess the importance of His59-
dependent hydrogen bonding on cysteine sulfenic acid stability.  Bailey et al. 
demonstrated that both H59Q and H59L/H157L Pin1 have isomerase activity, 
allowing the former to be used as a positive control for the availability of 
hydrogen bonding with cysteine sulfenic acid and the latter as a negative.14  The 
isomerase activity rescue assays could be used to compare the effects of DTT on 
H2O2-mediated inhibition between wild-type, H59Q ( which can form hydrogen 
bonds), and H59L/H157L Pin1 (which cannot).  In order to explore the 
importance of His59 tautomerization on cysteine sulfenic acid stabilization, the 
assays could be repeated at varying pH, dependent on the functional pH range of 
the assay.  At more basic pH, the π tautomer of His59 should predominate, 
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thereby potentially improving the effects of DTT on isomerase activity.  The 
findings from these assays should guide the hydrogen peroxide treatment used to 
attain the crystal structure of Pin1 with cysteine cysteine sulfenic acid.  Since this 
moiety has been identified in other x-ray crystallography experiments, it should 
be attainable.75 
Since the current study was limited to in vitro techniques, it is possible 
that an alternative mechanism for redox regulation was overlooked, specifically 
the possibility of intermolecular disulfide bonding.  The potential for this process 
in the redox regulation of Pin1 could be assessed by modifying the techniques 
outlined by Cumming in 2008.88  Specifically, Pin1 would be overexpressed in 
cultured cells which would then then be subjected to treatment with H2O2.  After 
isolating Pin1 complexes from the lysates in non-reducing conditions by 
immunoprecipitation, the resulting solution would be separated by SDS-PAGE, 
and interacting proteins identified by mass spectrometry. 
As outlined in the introduction, a current focus of this lab is the various 
binding modalities of Pin1.  Given the potential steric hinderance of cysteine 
sulfenic acid during substrate interaction with the Pin1 isomerase domain, it 
would be interesting to explore the binding properties of oxidized Pin1.  This 
could be performed using a similar pulldown technique to that of Innes et al.,9 
comparing those proteins interacting with oxidized Pin1 to those of the isomerase 
binding-deficient mutant, R68A/R69A Pin1, and wild-type.  The different 
substrate interaction patterns for wild-type and oxidized Pin1 could yield insights 
into the potential functional roles of redox regulation of Pin1. 
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These proposed experiments assess the validity of the hypothesis that 
stabilization cysteine sulfenic acid requires a proximal hydrogen bonding partner.  
If this is demonstrated to be the case, this would reinforce the model proposed by 
Kulathu et al.,75 in which low pKa cysteines with a nearby hydrogen bond donor 
may be the target of oxidation-mediated sulfenylation, thereby making them 
possible candidates for physiological redox regulation.  This model could guide 
the search for other enzymes undergoing redox regulation.  The workflow would 
be as follows:  
1. Using an annotated database of structures deposited in the protein 
data bank, identify proteins with solvent exposed cysteines.89 
2. Using publish pKa prediction software, identify those cysteines 
which have sufficiently low pKa values to be considered 
susceptible to oxidation.84 
3. Either using a simple vector search algorithm, or simply measuring 
vector distances between every potential hydrogen bond-donating 
atom in the protein and the γ-sulfur of the low pKa cysteine, 
determine whether an appropriate hydrogen bonding partner is 
available for each cysteine. 
4. Finally, determine whether the identified cysteine is important for 
catalysis for each successful enzyme. 
The validity of the resulting list could be assessed by selecting one or 
more enzymes predicted to be redox regulated, and assaying their enzyme activity 
following treatment with H2O2 and subsequent rescue by DTT. 
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The field of redox regulation is growing with the development of more 
effective and accessible techniques for analysis of redox modification.  However, 
the focus has thus far been on identifying oxidized proteins in tissues and 
pathologies, the results of which may be overlooked by the enzymology 
community.  By applying a set of criteria for global assessment of the molecular 
impact of redox regulation, the proposed experiments seek to trigger a new front 
in the progression of the redox regulation field, driven by biochemical studies of 
enzyme activity, in order to establish redox regulation as another important 
cellular signaling mechanism. 
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